Yeah, NYR have played the simpletons and bagholders like Benny and Kyriaco for the raise pump, played them very well to their credit.
$25m MC for a preclinical mouse company with one lonely compound, no pipeline, history of failure, no IP protection, and a very dodgy NOX holding capping any moves, is frankly insane. And a sign that bio sector is perhaps overcooked now, once again....
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
0.025(10.6%) |
Mkt cap ! $54.83M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 26.5¢ | 23.5¢ | $352.7K | 1.440M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3600 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 4499 | 1 |
View Market Depth
| Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
| NYR (ASX) Chart |